◆ Listed stock · ARGX

argenx

Autoimmune disease biotechnology.

Open the chart

◆ Live market

…

24h

—

Ticker
ARGX
Category
Stocks & ETFs
Type
Listed stock
Group
Healthcare & Biotech
Trading hours
Market sessions

What is argenx?

Biotechnologie des maladies auto-immunes. A share represents part ownership of a listed company. Its price reflects investors' expectations of future earnings.

How argenx works and what gives it value

The stock reacts to quarterly results, management guidance, sector news and the rate backdrop. Earnings releases often cause big opening gaps.

What moves the price of argenx

  • ◆Earnings and guidance
  • ◆Interest rates
  • ◆Sector news
  • ◆Buybacks and dividends

Key metrics to watch

  • ◆Revenue growth
  • ◆Margins
  • ◆P/E ratio
  • ◆Earnings dates

Risks specific to argenx

  • ◆Earnings disappointments
  • ◆High valuation
  • ◆Regulatory risk

How to analyse argenx on GraphTrade

Daily and weekly; market open only during sessions. Open the ARGX chart, add the indicators below, compare argenx with similar assets in Performance and ask the AI Compass to explain the latest move with news and macro context.

Themes

Included in: Santé & biotechnologies.

◆ Indicators suited to argenx

◆ FAQ

What is argenx (ARGX)?

Autoimmune disease biotechnology.

Why is argenx going up or down today?

The main drivers are: earnings and guidance, interest rates, sector news, buybacks and dividends. The AI Compass cross-references these with today's news.

Which indicators work best on argenx?

Daily and weekly; market open only during sessions.

What are the risks of argenx?

Earnings disappointments ; High valuation ; Regulatory risk.

How do I follow argenx in real time?

Open the free GraphTrade chart for ARGX: price updates live, with all indicators.

How do I add argenx to my portfolio?

Click « Add to portfolio » on this page: the asset joins your active portfolio.

Is this investment advice?

No. GraphTrade provides information and analysis tools only.

◆ Assets similar to argenx

Information only, not investment advice.